Tag: podcast

  • Immunotherapy for Glioblastoma with Adam Sonabend, MD

    Immunotherapy for Glioblastoma with Adam Sonabend, MD

    Immunotherapy has revolutionized cancer treatment over the last few decades, though not for glioblastoma — the most common and deadly malignant brain tumor. However, Northwestern Medicine neurosurgeon Adam Sonabend, MD, shares promising research on the potential benefits of immunotherapy for certain glioblastoma patients.

  • COVID-19 Boosters Increase Protection with Alexis Demonbreun, PhD

    COVID-19 Boosters Increase Protection with Alexis Demonbreun, PhD

    What do we know about the effectiveness of COVID-19 boosters, and how might they better protect us from new variants such as omicron? Alexis Demonbreun, PhD, assistant professor of Pharmacology, offers insight. She is the author of a new study that shows COVID-19 boosters seem to supercharge antibody response.

  • Human Genome Project for Proteins with Neil Kelleher, PhD

    Human Genome Project for Proteins with Neil Kelleher, PhD

    Millions of molecular proteins are swimming through our body’s cells and many studies have discovered that these proteins are the main drivers of all human diseases. Scientists are now mapping proteins the way the Human Genome Project mapped genes. Neil Kelleher, PhD, director of Northwestern Proteomics, is at the forefront of the Human Proteoform Project…

  • Reversing Severe Spinal Cord Injuries with Samuel Stupp, PhD

    Reversing Severe Spinal Cord Injuries with Samuel Stupp, PhD

    Regenerative nanomedicine is being used to develop new therapies for devastating conditions such as severe spinal cord injuries. Northwestern’s Samuel Stupp, PhD, is a pioneer in the field of regenerative nanomedicine and recently published a paper in the journal Science that details how a new injectable therapy uses synthetic nanofibers to reverse severe spinal cord…

  • Earliest Signs of Parkinson’s Disease with D. James Surmeier, PhD

    Earliest Signs of Parkinson’s Disease with D. James Surmeier, PhD

    Northwestern Medicine scientists have discovered one of the earliest signs of Parkinson’s disease, proving that damaged neuronal mitochondria alone can cause symptoms of the disease, according to a study published in Nature. Senior author D. James Surmeier, PhD, chair of the Feinberg department of Neuroscience, who has over 30 years of experience in the field,…

  • The Northwestern Medicine African American Transplant Access Program with Dinee Simpson, MD

    The Northwestern Medicine African American Transplant Access Program with Dinee Simpson, MD

    People who are Black make up the largest group of minorities in need of an organ transplant. In 2019, Northwestern Medicine launched the African American Transplant Access Program to help address this problem. Founding director of the program Dinee Simpson, MD, talks about the barriers to organ transplant for Black patients and how she is…

  • Variants of Interest and of Concern with Judd Hultquist, PhD

    Variants of Interest and of Concern with Judd Hultquist, PhD

    Judd Hultquist, PhD, talks about key variants of SARS-CoV-2 and how his lab is identifying and studying these variants.

  • Advancing Muscular Dystrophy Research with Elizabeth McNally, MD, PhD

    Advancing Muscular Dystrophy Research with Elizabeth McNally, MD, PhD

    Elizabeth McNally, MD, PhD, talks about her recent discoveries advancing muscular dystrophy research.

  • Next-Generation COVID Vaccines with Pablo Penaloza-MacMaster, PhD

    Next-Generation COVID Vaccines with Pablo Penaloza-MacMaster, PhD

    As the Delta variant of SARS-CoV-2 is causing breakthrough infections in some vaccinated people around the world, scientists at Northwestern Medicine are developing and studying potential next-generation COVID-19 vaccines that could be more effective at preventing and clearing breakthrough infections. Pablo Penaloza-MacMaster, PhD, an assistant professor of Microbiology-Immunology at Feinberg, discusses work in his lab…